Degrees and Honours
MD; PhD; MRCPsych;
Membership of Professional Bodies / Associations
Royal College of Psychiatrists
British Medical Association
American Neuroscience Association
British Neuroscience Association
British Association of Psychopharmacology
World Federation of Societies of Biological Psychiatry
Royal Society of Biology
Profile
Professor Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology and Director of the Cambridge Centre for Neuropsychiatric Research at Cambridge University. Her main research interests are to understand the molecular basis of neuropsychiatric disorders and develop novel diagnostics and therapeutics for psychiatric disorders, with a focus on schizophrenia and mood disorders.
Professor Bahn has published over 180 articles in high impact journals and has co-founded 2 spin-out companies. In 2005, she co-founded Psynova Neurotech Ltd, an award winning company, which has launched the first blood test aiding in the early diagnosis of schizophrenia. In 2011 Psynova Neurotech was acquired by Myriad Genetics, a NASDAQ listed diagnostics company. In 2015 she co-founded a new company, PsyOmics Ltd. PsyOmics aims to develop combined digital and blood based biomarker diagnostics to facilitate earlier and improved diagnosis of key mental health disorders, especially bipolar disorder and depression.
She is a Fellow of Lucy Cavendish College.
Publications (selected)
- E. Schwarz, Y. Levin, L. Wang, M. Leweke & S. Bahn - 'Peptide correlation: A means to identify high quality quantitative information in large scale proteomic studies', J.Sep. Sci, August, 7;30(14): 2190-2197, (2007).
- Y. Levin, E. Schwarz, L. Wang, M. Leweke & S. Bahn - 'Label free LC-MSMS quantitative proteomics for large scale biomarker discovery in complex samples', J.Sep. Sci, August 2;30(14): 2198-2203, 2007).
- T.J. Huang, F.M. Leweke, T.M. Tsang, D. Koethe, C.W. Gerth, B.M. Nolden, S. Gross, K. Schreiber, E. Holmes & S. Bahn - 'CSF metabolic and proteomic profiles in patients prodromal for psychosis', PLoS One, August 22;2:e756, (2007).
- E. Schwarz, Y. Levin, L. Wang, M. Leweke & S. Bahn - 'Peptide correlation: A means to identify high quality quantitative information in large scale proteomic studies', J.Sep. Sci, August, 7;30(14):2190-2197, (2007).
- S. Bahn - 'Gene expression in bipolar disorder and schizophrenia: new approaches toold problems', Bipolar Disord., 4, Suppl 1:70-2, (2002).
Reviews:
- K.E. Wilson, M.M. Ryan, J.E. Prime, P.D. Pashby, P.R. Orange, G. O'Beirne, J.G. Whateley, S. Bahn & C.M. Morris - 'Functional Genomics and Proteomics: Application in Neurosciences'. J. Neurology Neurosurg Psychiatry, 75(4):529-538, (2004).
- S. Bahn, M. Ryan, S. Augood, M. Mimac & P. Emson - 'Gene expression in the post-mortem human brain - no cause for dismay', J. Chem. Neuroanat., 22, 79-94, (2001).
Books/ Book chapters:
- S. Hemby & S. Bahn (editors) - Functional Genomics and Proteomics in the Clinical Neurosciences, Elsevier, (2006).
- S. Bahn - 'Gene expression in psychotic disorders: dissecting the basis of complex neuropsychiatric disorders', Search for the Causes of Schizophrenia, Volume 5, Gattaz & Haefner (editors), Springer, (2004).
- M. Starkey, S. Bahn & H. Mahadeva - 'Indexing-based differential display', Analysing Gene Expression, P. Lorkowski & P. Cullen (editors), Wiley-VCH, (2002).
- S.Bahn & W. Wisden - 'A map of non-NMDA receptor subunit expression in the vertebrate brain derived from in situ hybridisation histochemistry', The Ionotropic Glutamate Receptors, D.T. Monaghan & R.T. Wenthold (editors), Humana Press, (1996).
